Department of Health Information Management and Medical Informatics, School of Allied Medical Sciences, Tehran University of Medical Sciences, 3th Floor, No #17, Farredanesh Alley, Ghods St, Enghelab Ave, Tehran, Iran.
Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.
BMC Med Inform Decis Mak. 2023 Jan 23;23(1):17. doi: 10.1186/s12911-023-02108-4.
BACKGROUND: Breast cancer is one of the most common cancers diagnosed worldwide and the second leading cause of death among women. Virtual reality (VR) has many opportunities and challenges for breast cancer patients' rehabilitation and symptom management. The purpose of this systematic review is to look into the benefits and drawbacks of VR interventions for breast cancer patients. METHODS: A systematic search was conducted on PubMed, Web of Science, Scopus, IEEE, and the Cochrane Library, from inception until February 6, 2022. The inclusion criteria were: (1) original studies without restriction in study design; (2) a study population consisting of patients with breast cancer; (3) any type of VR-based interventions (immersive and non-immersive); and (5) studies published in English. To assess the risk of bias, the Effective Public Health Practice Project (EPHPP) Tool was used. RESULTS: Eighteen articles were included in this systematic review. The result showed that VR could provide many opportunities for patients with breast cancer, including reducing anxiety, time perception, pain, fatigue, chemotherapy-related symptom distress levels, and depression severity, as well as improvement in the range of motion, strength, and function. Cybersickness symptoms, the weight of headsets and helmets, the quality of the visual image, and the cost of the equipment are some of the challenges in using this technology on these patients. CONCLUSIONS: The systematic review showed that VR interventions have opportunities and challenges for patients with breast cancer. VR can be effective for rehabilitation and symptom management and is used in different stages of treatment to improve the condition of patients with breast cancer. However, before using it, the researcher should consider its challenges.
背景:乳腺癌是全球最常见的癌症之一,也是女性死亡的第二大主要原因。虚拟现实(VR)在乳腺癌患者的康复和症状管理方面有许多机会和挑战。本系统评价的目的是研究 VR 干预对乳腺癌患者的益处和弊端。
方法:从建库到 2022 年 2 月 6 日,我们在 PubMed、Web of Science、Scopus、IEEE 和 Cochrane Library 上进行了系统搜索。纳入标准为:(1)原始研究,设计不受限制;(2)研究人群为乳腺癌患者;(3)任何类型的基于 VR 的干预措施(沉浸式和非沉浸式);(4)研究人群为乳腺癌患者;(5)以英文发表的研究。采用有效公共卫生实践项目(EPHPP)工具评估偏倚风险。
结果:本系统评价纳入了 18 篇文章。结果表明,VR 可为乳腺癌患者提供许多机会,包括降低焦虑、时间感知、疼痛、疲劳、化疗相关症状困扰程度和抑郁严重程度,以及改善运动范围、力量和功能。使用该技术对这些患者存在一些挑战,如晕动病症状、耳机和头盔的重量、视觉图像质量和设备成本。
结论:本系统评价表明,VR 干预措施对乳腺癌患者既有机会也有挑战。VR 对康复和症状管理有效,用于治疗的不同阶段,以改善乳腺癌患者的状况。然而,在使用之前,研究人员应考虑其挑战。
BMC Med Inform Decis Mak. 2023-1-23
Support Care Cancer. 2024-8-5
Breast Care (Basel). 2025-6-11
Support Care Cancer. 2025-7-9
Health Res Policy Syst. 2025-4-29
Cancers (Basel). 2024-11-25
Cancers (Basel). 2022-6-28
JCO Clin Cancer Inform. 2021-10
Int J Environ Res Public Health. 2021-8-19